Shingo Eikawa
Impact in
- Immunology top 5%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 13
- T-cell and B-cell Immunology 7
- Immunotherapy and Immune Responses 7
- Immune cells in cancer 1
- Oncology 11
- Cancer Immunotherapy and Biomarkers 10
- Co-authors
- Heiichiro Udono (13 shared papers)Eiichi Nakayama (7 shared papers)Mikako Nishida (2 shared papers)Shusaku Mizukami (3 shared papers)Chihiro Yamazaki (2 shared papers)Yuki Kunisada (3 shared papers)Takenori Uehara (2 shared papers)Akiko Uenaka (6 shared papers)
- Journals
- Scientific Reports (2 papers)International Journal of Cancer (2 papers)Gene Therapy (1 paper)Nature Medicine (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)
- Partner nations
- JapanUnited StatesFinland
In The Last Decade
Shingo Eikawa
20 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 70
- Immunology 336
- Oncology 361
- Cancer Research 97
- Molecular Biology 377
- Aging 4
Countries citing papers authored by Shingo Eikawa
This map shows the geographic impact of Shingo Eikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shingo Eikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shingo Eikawa more than expected).
Fields of papers citing papers by Shingo Eikawa
This network shows the impact of papers produced by Shingo Eikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shingo Eikawa. The network helps show where Shingo Eikawa may publish in the future.
Co-authors
The 25 scholars most cited alongside Shingo Eikawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 482 | |
| 2 | 2017 | 136 | |
| 3 | 2018 | 105 | |
| 4 | 2019 | 71 | |
| 5 | 2010 | 55 | |
| 6 | 2014 | 51 | |
| 7 | 2020 | 46 | |
| 8 | 2011 | 35 | |
| 9 | 2014 | 30 | |
| 10 | 2012 | 27 | |
| 11 | 2012 | 22 | |
| 12 | Correlation of high and decreased NY-ESO-1 immunity to spontaneous regression and subsequent recurrence in a lung cancer patient. | 2009 | 14 |
| 13 | 2023 | 11 | |
| 14 | 2014 | 9 | |
| 15 | 2015 | 5 | |
| 16 | 2026 | 5 | |
| 17 | 2016 | 4 | |
| 18 | 2016 | 4 | |
| 19 | [Metabolic Competition in Tumor Microenvironment]. | 2017 | 3 |
| 20 | Metformin-dependent metabolic reprogramming contributes to efficient anti-tumor immunity. | 2017 | 1 |
About Shingo Eikawa
Shingo Eikawa is a scholar working on Immunology, Oncology, Molecular Biology, Immunology and Allergy and Cancer Research, having authored 21 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), T-cell and B-cell Immunology (7 papers), Immunotherapy and Immune Responses (7 papers), Metabolism, Diabetes, and Cancer (5 papers), Cancer, Hypoxia, and Metabolism (1 paper), Heat shock proteins research (1 paper), Immune cells in cancer (1 paper) and Berberine and alkaloids research (1 paper). The work is most often cited by research in Immunology (336 citations), Oncology (361 citations), Cancer Research (97 citations), Molecular Biology (377 citations) and Aging (4 citations). Shingo Eikawa has collaborated with scholars based in Japan, United States and Finland. Frequent co-authors include Heiichiro Udono, Eiichi Nakayama, Mikako Nishida, Shusaku Mizukami, Chihiro Yamazaki, Yuki Kunisada, Takenori Uehara, Akiko Uenaka, Mikio Oka and Yoshihiro Ohue. Their work appears in journals such as Scientific Reports, International Journal of Cancer, Gene Therapy, Nature Medicine and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.